- All efficacy endpoints were comparable during long-term treatment in the maintenance and switch groups21
*CT-P13 is marketed under different brand names including INFLECTRA® and REMSIMA®.
†Remicade® is a registered trademark of MSD.
AS, Ankylosing spondyloarthritis; ASAS, Assessment of Spondyloarthritis International Society; CI, Confidence interval; OR, Odds ratio.
PP-IFA-GBR-0290. December 2018